Clinical & translational oncology

• 

  Año 2024, Vol. 26, Número 2

  • Glioblastoma research on zebrafsh xenograft models: a systematic review

    Alexandra Pliakopanou, Ilias Antonopoulos, Nikolia Darzenta, Iliana Serifi, Yannis Vasilios Simos, Andreas Panagiotis Katsenos, Stefanos Bellos, George Athanasios Alexiou, Athanasios Petros Kyritsis, Ioannis Leonardos, Patra Vezyraki, D. Peschos, Ioannis Tsamis

    • Resumen

    págs. 311-325

    

  • Mechanism of action and treatment of type I interferon in hepatocellular carcinoma

    Chunxiu Peng, Zhijian Ye, Ying Ju, Xiuxin Huang, Chenjie Zhan, Ke Wei, Zhiyong Zhang

    • Resumen

    págs. 326-337

    

  • Energy metabolism: a new target for gastric cancer treatment

    Jiangrong Liu, Xue Bai, Meilan Zhang, Shihua Wu, Juan Xiao, Xuemei Zeng, Yuwei Li, Zhiwei Zhang

    • Resumen

    págs. 338-351

    

  • The role of sex and gender in the diagnosis and treatment of lung cancer: the 6th ICAPEM Annual Symposium

    Núria Viñolas Segarra, Laura Mezquita Pérez, J. Corral, Manuel Cobo Dols, Francisco Luis Gil Moncayo, Luis Paz-Ares Rodríguez, Jordi Remón Masip, M. E. Rodríguez Ruiz, Alberto Ruano Raviña, E. Conde Gallego, Margarita Majem, María Pilar Garrido López, Enriqueta Felip Font, Dolores Isla Casado, Javier de Castro Carpeño

    • Resumen

    págs. 352-362

    

  • MicroRNA-128 acts as a suppressor in the progression of gastrointestinal stromal tumor by targeting B-lymphoma Mo-MLV insertion region 1

    Jinbao Wu, Changjuan Wang, Xia Cui, Lin Liu, Lu Wang, Jing Wang, Xiaohui Xue, Tong Dang

    • Resumen

    págs. 363-374

    

  • A nomogram based on 4-lncRNAs signature for improving prognostic prediction of hepatocellular carcinoma

    Qingguo Mo, Wenjing Li, Lin Liu, Zhidong Hao, Shengjun Jia, Yongsheng Duo

    • Resumen

    págs. 375-388

    

  • Prognostic model of ER-positive, HER2-negative breast cancer predicted by clinically relevant indicators

    Xinming Song, Pintian Wang, Ruiling Feng, Mandika Chetry, E.M. Li, Xiaohua Wu, Zewa Liu, Shasha Liao, Jing Lin

    • Resumen

    págs. 389-397

    

  • Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation

    Yajun Miao, Jun Liu

    • Resumen

    págs. 398-413

    

  • LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma

    Zhiyong Zhang, Guohong Jiang, Juan Lu, Lina Wang

    • Resumen

    págs. 414-423

    

  • Surface guided radiation therapy with an innovative open-face mask and mouth bite: patient motion management in brain stereotactic radiotherapy

    Xuemei Chen, Lu Liu, Yajuan Wang, Xiaotong Huang, Weixun Cai, Xiaodong Rong, Liuwen Lin, Jindi Liu, Xiaobo Jiang

    • Resumen

    págs. 424-433

    

  • Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS era

    Xiaohong Xie, Guihuan Qiu, Ziyao Chen, Ting Liu, Yilin Yang, Zhixuan You, Chen Zeng, X. Lin, Zhanhong Xie, Yinyin Qin, Yansheng Wang, Xiaodong Ma, C. Zhou, Ming Liu

    • Resumen

    págs. 434-445

    

  • Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival

    Yaxiong Tang, Lede Lin, Yunfei Xiao, Linghao Meng, Yujia Yang, Xiang Li

    • Resumen

    págs. 446-455

    

  • Status of head and neck brachytherapy in Spain in 2022

    José Luis Guinot Rodríguez, Patricia Diezhandino, Jesús Frutos Baraja, Naiara Fuentemilla Urio, Víctor González Pérez, Cristina Gutiérrez, Antonio Herreros, Rafael Martínez, S. Pérez Echagüen, Francisco Pino, S. Roldán, Angeles Rovirosa Casino, Miguel Ángel Santos, Camilo Jose Sanz Freire, Elena Villafranca Iturre

    • Resumen

    págs. 456-460

    

  • Bone metastatic cancer of unknown primary at initial presentation

    Masatake Matsuoka, T. Onodera, Isao Yokota, K. Iwasaki, Yuki Suzuki, Hamasaki Masanari, E. Kondo, N. Iwasaki

    • Resumen

    págs. 461-467

    

  • Efficacy and safety of trifluridine/tipiracil (TAS-102) in patients with metastatic colorectal cancer: a systematic review and meta-analysis

    Fengxiang Huang, Haiyan Yang, Wenguang Bao, Yehong Bin, Shengsheng Zhou, Man Wang, Xiaoping Lv

    • Resumen

    págs. 468-476

    

  • A gene signature of cancer-associated fibroblasts predicts prognosis and treatment response in bladder cancer

    Xi Chen, Chunyan Liao, Xiong Zou, Bei Zhang, Zengnan Mo

    • Resumen

    págs. 477-495

    

  • The role of the mitochondrial ribosomal protein family in detecting hepatocellular carcinoma and predicting prognosis, immune features, and drug sensitivity

    Jin Wei Zhao, Wei Yi Zhao, Xin Hua Cui, Lin Xing, Jia Cheng Shi, Lu Yu

    • Resumen

    págs. 496-514

    

  • Prognostic value of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: a meta-analysis

    Chengkun Yan, Yanyou Xie, Yaqi Hua, Sihui Li, Huanxu Fu, Zhiqiang Cheng, Jiehua Wu

    • Resumen

    págs. 515-523

    

  • Is surgical indication in multiple myeloma a poor prognosis sign? SEER database analysis

    Recep Öztürk, Kamil Amer, Ayşe Tuğçenur Gençoğlu, Fatma Gökçenur Öztürk, K. Kasali, Mahmut Nedim Aytekin

    • Resumen

    págs. 524-531

    

  • Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors

    Alvaro Pinto Marín, Jesús Miranda, Ana Pertejo Fernández, Mario Álvarez Maestro, Pilar González Peramato, Alfredo Aguilera Bazán, M.Eugenia García Fernández, Lucía Trilla, Angelo Gámez Pozo, E. Espinosa Arranz

    • Resumen

    págs. 532-537

    

  • Proteomics-based clustering of lung adenocarcinoma identifies three subtypes with significantly different clinical and molecular features

    Rongzhuo Long, Nayila Abulimiti, Xiaosheng Wang

    • Resumen

    págs. 538-548

    

  • Neoadjuvant chemotherapy with dose-dense MVAC in muscle-invasive bladder cancer: a tertiary center experience

    Marina Serrano, Nerea Muñoz Unceta, Lucía Alonso Buznego, Ainara Azueta Etxebarria, José Luis Gutiérrez Baños, Laura Ferreira, Mario Domínguez Esteban, Albero Torres Zurita, Roberto Ballestero Diego, Diego Cacho Lavín, Marta López-Brea, Marta Sotelo García, Félix Campos Juanatey, Enrique Ramos Barseló, Ignacio Durán

    • Resumen

    págs. 549-553